It targets three different hormone receptors GLP-1, GIP, and glucagon which may help to reduce appetite, regulate blood sugar levels, and support fat loss
By understanding your genetic profile, PlexusDx providers can personalize your semaglutide dose, anticipate which dosing schedule optimizes your insulin sensitivity, and identify complementary medications that work synergistically with your genetics
Orphan drugs are those developed for rare diseases, and Ipamorelin is generally used in the context of growth hormone therapies and related applications
Nausea - the most common side effect, reported more frequently at higher doses Diarrhoea Vomiting Constipation Abdominal pain or discomfort These side effects were generally mild to moderate in severity and were most common during the dose escalation period (the first 1216 weeks of treatment, when the dose is gradually increased)
Tirzepatide is a dual-action therapy that targets multiple pathways involved in appetite regulation and metabolic function
Wegovy users have also reported hospitalization due to gastroparesis (stomach paralysis), was not mentioned on the drugs warning label until October 2025